Findings from University of Mainz, Germany, research reported

This trend article about University of Mainz, Germany, is an immediate alert from NewsRx to identify developing directions of research.

Study 1: Investigators publish new data in the report "Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain." According to recent research published in the British Journal of Clinical Pharmacology, "The purpose of the current study was to establish the safety and maximal tolerated dose of CNS 5161 HCl. Forty patients with chronic neuropathic pain (23 male, 17 female)...

Want to see the full article?

• Purchase this article for only $3.00